Shop By Brands
S
Shop By Brand
S
€221.00
Product information
| Active substances | HYALURONIC ACID, LIDOCAINE |
|---|---|
| Manufacturer | Prollenium Medical Technologies Inc |
| Pack size | 2 x 1.2ml Pre-Filled Syringes, 2 x Needles |
| Strength | 25mg HA, 3mg/ml Lidocaine |
We guarantee your order will arrive quickly. Most parcels are delivered within 1–3 business days, ensuring you get the products you need when you need them.
Enjoy personalized support with a dedicated account manager. From product selection to tracking, you’ll always have a trusted partner by your side.
Shop confidently from our wide range of 300+ verified products. Every item is ready to ship, giving you reliable access to trusted medical solutions.
We supply only authentic products, backed by full traceability. Every order comes with confidence, transparency, and assurance of verified sourcing.
Revanesse Shape+ with Lidocaine is specifically designed for deep tissue augmentation and contouring. It is used in:
Prollenium Medical Technologies, based in Ontario, Canada, manufactures Revanesse Shape+ with Lidocaine. Professionals can purchase other products in the Revanesse range, such as:
Revanesse Shape+ with Lidocaine dermal fillers offers numerous benefits for both patients and practitioners:
This filler is formulated with high-quality ingredients to ensure safety and effectiveness.
Key ingredients:
Device properties:
Each package of Revanesse Shape+ with Lidocaine includes:
Revanesse Shape+ should be administered by trained medical professionals following these steps:
Pre-procedure:
During procedure:
Post-procedure:
Patients should follow these post-treatment recommendations:
The results of Revanesse Shape+ can last 9-12 months, depending on the treatment area and patient metabolism.
While Revanesse Shape+ with Lidocaine is a safe and well-tolerated dermal filler, patients may experience temporary or, in rare cases, serious side effects.
Common side effects:
Rare side effects:
Revanesse Shape+ with Lidocaine is not suitable for everyone. Before administering treatment, medical professionals must conduct a thorough patient assessment to identify contraindications and ensure safety: